Up
| AC Home
Page
Food and
Drug Administration
Arthritis Drugs Advisory Committee
November 29, 2006
Briefing Information
FDA
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily
agree with the sponsor's statements. FDA has not made a final
determination about the safety or effectiveness of the product
described in this document.
FDA
FDA Briefing Document (pdf)
Bibliography (pdf)
Pfizer Inc.
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the
FOIA) (5 U.S.C. §552). These redacted portions will appear
as white space on the screen or on the printed page.
Pfizer Briefing Document (pdf)
Errata for Briefing Document (pdf)